Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED SULCONAZOLE NITRATE cream 1.0% is a smooth, glossy white to off-white cream having a slight characteristic odor. It is supplied as follows: 60 g tube - NDC 72143-311-60 Avoid excessive heat, above 40° C (104° F). To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . Manufactured for: JG Pharma Scottsdale, AZ 85258 www.JGPharmainc.com 141079 September 2019; Principal Display Panel – 60g Carton Label JG Pharma NDC 72143-311-60 Rx only sulconazole nitrate cream , 1.0% Net Wt. 60 g Principal Display Panel – 60g Carton Label; Principal Display Panel – 60g Tube Label JG Pharma NDC 72143-311-60 Rx only sulconazole nitrate cream , 1.0% Avoid excessive heat, above 40°C (104° F). Net Wt. 60 g For topical use only. Not for ophthalmic use. Principal Display Panel – 60g Tube Label
- HOW SUPPLIED SULCONAZOLE NITRATE cream 1.0% is a smooth, glossy white to off-white cream having a slight characteristic odor. It is supplied as follows: 60 g tube - NDC 72143-311-60 Avoid excessive heat, above 40° C (104° F). To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . Manufactured for: JG Pharma Scottsdale, AZ 85258 www.JGPharmainc.com 141079 September 2019
- Principal Display Panel – 60g Carton Label JG Pharma NDC 72143-311-60 Rx only sulconazole nitrate cream , 1.0% Net Wt. 60 g Principal Display Panel – 60g Carton Label
- Principal Display Panel – 60g Tube Label JG Pharma NDC 72143-311-60 Rx only sulconazole nitrate cream , 1.0% Avoid excessive heat, above 40°C (104° F). Net Wt. 60 g For topical use only. Not for ophthalmic use. Principal Display Panel – 60g Tube Label
Overview
SULCONAZOLE NITRATE cream 1.0% is a broad-spectrum antifungal agent intended for topical application. Sulconazole nitrate, USP, the active ingredient in SULCONAZOLE NITRATE cream, is an imidazole derivative with in vitro antifungal and antiyeast activity. Its chemical name is (±)-1-[2,4-Dichloro-β-[( p -chlorobenzyl)thio] phenethyl]imidazole mononitrate and it has the following chemical structure: Sulconazole nitrate, USP is a white to off-white crystalline powder with a molecular weight of 460.77. It is freely soluble in pyridine; slightly soluble in ethanol, acetone, and chloroform; and very slightly soluble in water. It has a melting point of about 130°C. SULCONAZOLE NITRATE cream contains sulconazole nitrate, USP 10 mg/g in an emollient cream base consisting of propylene glycol, stearyl alcohol, isopropyl myristate, cetyl alcohol, polysorbate 60, sorbitan monostearate, glyceryl stearate (and) PEG-100 stearate, ascorbyl palmitate, and purified water, with sodium hydroxide and/or nitric acid added to adjust the pH. Chemical Structure
Indications & Usage
SULCONAZOLE NITRATE cream 1.0% is an antifungal agent indicated for the treatment of tinea pedis (athlete's foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagro- phytes, Epidermophyton floccosum , and Microsporum canis ,* and for the treatment of tinea versicolor.
Dosage & Administration
A small amount of cream should be gently massaged into the affected and surrounding skin areas once or twice daily, except in tinea pedis, where administration should be twice daily. Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, tinea corporis/cruris and tinea versicolor should be treated for 3 weeks and tinea pedis for 4 weeks to reduce the possibility of recurrence. If significant clinical improvement is not seen after 4 to 6 weeks of treatment, an alternate diagnosis should be considered.
Warnings & Precautions
No warnings available yet.
Contraindications
SULCONAZOLE NITRATE cream 1.0% is contraindicated in patients who have a history of hypersensitivity to any of its ingredients.
Adverse Reactions
There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream in controlled clinical trials. Approximately 3% of these patients reported itching, 3% burning or stinging, and 1% redness. These complaints did not usually interfere with treatment.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.